Archive · 22 May 2025
Lupin Launches Sustainable Respiratory Inhalers with Honeywell
Lupin is now using Honeywell's Solstice Air in its asthma and COPD inhalers.
This change is a big deal because it uses a special propellant that is much better for the environment.
The new inhalers aim to reduce the release of harmful greenhouse gases.
By using Solstice Air, Lupin hopes to reduce carbon emissions significantly.
The goal is to provide safe and effective treatments while also helping the planet.
Honeywell is working to develop technologies that make healthcare more eco-friendly, showing that businesses can improve health solutions and cut emissions.
Lupin is using Honeywell Solstice Air in its respiratory inhalers.
The new inhalers are designed for asthma and COPD patients.
Honeywell Solstice Air aims to reduce greenhouse gas emissions by up to 99.9%.
Vinita Gupta, CEO of Lupin, stated the integration enhances patient care and reduces environmental impact.
Ashish Modi, President of Honeywell India, highlighted the importance of reducing harmful greenhouse gas emissions.
- Who
- Lupin and Honeywell
- What
- Lupin is using Honeywell Solstice Air in respiratory inhalers
- When
- Not specified
- Where
- Bengaluru
- Why
- To reduce carbon emissions in respiratory care.
- Company
- Lupin
- Partnership
- Lupin and Honeywell
- Product
- Respiratory inhalers
- Technology
- Honeywell Solstice Air
- Purpose
- Reduce carbon emissions
- Target Patients
- Asthma and COPD patients